Back to News
Jan 12, 2026 8:00 AM

Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation

GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions, Inc. (NYSE:EBS) announced it made a voluntary prepayment of $100 million under its outstanding term loan facility in late December 2025 using cash on hand.

"This significant milestone reflects strong progress in improving our overall financial/cash position, enhancing our financial flexibility and positioning Emergent for long-term stability and growth," stated Joe Papa, president and CEO of Emergent. "We continue to maintain a strong cash position for future strategic initiatives that are aligned with our mission, drive our turnaround plan and ultimately help deliver on our transformation efforts in 2026 and beyond."

Since 2023, and now with this prepayment in effect, Emergent's gross debt has been reduced by $275 million, to a total of $593 million (pro forma as of September 30, 2025). This represents a 32 percent decline in total debt since Emergent has undertaken its multi-year transformation plan.

For more information, join